← Leaderboards
Hannah Augusta Valantine
Stanford University
$3,221,377
Attributed
$4,453,348
Total exposure
5
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $4.4M · FY2005–10$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
Funding mix
By agency
NIH$4,453,348 · 5
By mechanism
RC4$2,463,942 · 1
DP4$1,973,881 · 1
M01$15,525 · 3
Top collaborators
- Stephen R Quake1 shared
Most similar at Stanford University
Same institution · by research overlap
- Kenan Christopher Garcia$35,612,900
- Juan Luis Mendoza$2,196,716
- Samuel Strober$36,157,957
- Marlene Rabinovitch$40,032,014
- Peter R Parham$35,417,272
Others in their field
Top investigators on “Biopsy”
- David Heimbrook · Leidos Biomedical Research, Inc.$97,871,847
- Gautam (george) Mitra · Leidos Biomedical Research, Inc.$53,523,213
- Ralph Parchment · Leidos Biomedical Research, Inc.$43,674,966
- Nancy Roche · Leidos Biomedical Research, Inc.$39,999,252
- Chris Karlovich · Leidos Biomedical Research, Inc.$38,534,220
- Peter Scott Heeger · Case Western Reserve University$37,822,090
Research focus
BiopsyHeart TransplantationImmune ResponseEndothelial CellsTransplantationGenotypeLifeDesignGrantInfectionTransplant RecipientsUltrasonographyChemokine ReceptorDiagnosticResourcesBloodArteriosclerosisCytomegalovirusBioinformaticsBehavioralAreaBasic ScienceCatalogsBase Sequence
Grant awards (6)
Genome Transplant Dynamics: non-invasive sequencing-based diagnosis of rejection$2,463,942
RC4 · FY2010 · AI · contact PI
Eradicating stereotype threat: intervening to retain and advance women faculty$1,973,881
DP4 · FY2010 · GM · contact PI
TRANSPLANT ARTERIOSCLEROSIS: VIRAL AND HOST MECHANISMS$3,511
M01 · FY2007 · RR · contact PI
TRANSPLANT ARTERIOSCLEROSIS: VIRAL AND HOST MECHANISMS$6,227
M01 · FY2006 · RR · contact PI
TRANSPLANT ARTERIOSCLEROSIS: VIRAL AND HOST MECHANISMS$4,009
M01 · FY2005 · RR
Transplant Arteriosclerosis: Viral and Host mechanisms$1,778
M01 · FY2004 · RR